Spectrum says bladder cancer drug fails, buys Allos
(Reuters) - Spectrum Pharmaceuticals Inc said its experimental drug to treat a common form of bladder cancer failed to significantly reduce the recurrence of tumors in late-stage trials, sending its...
No comments:
Post a Comment